2 things for your valuations calculations - where do you think the SP will be if 50% of shorts close (which I don't think is unreasonable expectation)?
Do you place any value on the future SynPath platform product that is being developed?
This new absorbable product range will have a massive addressable market in hernia and breast and probably a lot of other uses that we don't know about yet. Its been pushed back to CY24 but it will have a big impact (IMHO) when launched and I expect sales to be much faster due to a larger sales force by then with well established contacts into the hospitals and PMOs.
PNV - Banter and General Comments, page-7771
-
- There are more pages in this discussion • 4,673 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
-0.090(3.57%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $2.49 | $2.50 | $2.43 | $2.311M | 940.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17100 | $2.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.45 | 5973 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |